Dr. Fels Saju is changing the game in medicine with 3D printing. He is an Associate Professor at Nirmala College of Pharmacy, alongside his collaborator, Mr. Binu, is leading the charge in this transformative technology poised to redefine medication delivery.
Tailored Treatments with 3D Printing
Unlike traditional tablet production methods that offer a one-size-fits-all approach, 3D printing allows for the creation of customised tablets tailored to individual patient needs. Dr. Fels Saju’s pioneering work holds the promise of personalised treatment plans, potentially minimising side effects and maximising therapeutic outcomes.
A Collaborative Endeavor
With essential support from Kerala Startup Mission’s idea grant, Dr. Fels Saju and his team received the necessary backing to turn their vision into reality. Mr. Jobin Johnson, an M.Pharm student, has played a pivotal role in advancing formulation development. Together, they have founded Simplified, a company dedicated to leveraging 3D printing for pharmaceutical innovation.
Revolutionising Healthcare Delivery
The implications of 3D printing extend far beyond convenience. Dr. Fels Saju envisions a future where patients receive medications tailored precisely to their unique health needs. Currently, the focus lies on developing sodium valproate tablets and 5-fluorouracil, an anti-cancer drug, with plans for expanding their portfolio in the future.
From Vision to Action
Dr. Fels Saju’s journey into 3D printing began with a spark of curiosity. Witnessing the capabilities of a 3D printer ignited his imagination, leading to extensive research and exploration within the healthcare domain. The discovery of FDA-approved tablets like Prita utilising this technology provided validation of its potential.
Dr. Fels Saju acknowledges that the integration of 3D printing into pharmaceutical manufacturing will require time and collaboration. However, through strategic partnerships with established pharmaceutical companies, they aim to accelerate the journey. Ultimately, the widespread adoption of this technology holds the promise of revolutionising medicine, one personalised tablet at a time.
